Test rtBank rt- rtPharmacology: rtA rtPatient-Centered rtNursing rtProcess rtApproach rt(9th rtEdition, rt2017)
PHARMACOLOGY rt9TH rtEDITION rtMCCUISTION rtTEST rtBANK
This rtis rta rtset rtof rtquestions rtto rtanswer rtthe rtquestions rtof rtthe rttextbook rt"Pharmacology: rtA rtPatient-
Centered rtNursing rtProcess rtApproach rt9th rtEdition" rtit rthelps rtyou rtto rtbetter rtunderstand rtthe rtbook
rtcorrectly.
Get rtthe rtright rtdosage rtof rtpharmacology rtcontent rtto rtsucceed rton rtthe rtNCLEX rtand rtas rta rtprofessional
rtnurse rtwith rt"Pharmacology: rtA rtPatient-Centered rtNursing rtProcess rtApproach, rt9th rtEdition". rtUsing rta
rtstreamlined rtprototype rtapproach rtand rtan rtemphasis rton rtnursing rtcare, rtthis rttext rtmakes rtit rteasy rtfor
rttoday’s rtnursing rtstudents rtto rtbetter rtunderstand rtthe rtcomplicated rtsubject rtof rtpharmacology. rtThe
rtbook’s rtdetailed rtchapter rton rtdosage rtcalculation, rtthe rtnursing rtprocess rtframework rtfor rtdrug rttherapy,
rtstrong rtQSEN rtfocus, rtand rtsummaries rtof rtprototype rtdrugs rthelp rtdeliver rtthe rtperfect.
,Test rtBank rt- rtPharmacology: rtA rtPatient-Centered rtNursing rtProcess rtApproach rt(9th rtEdition,
rt2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Table of Contents
rt rt
Table rtof rtContents Chapter rt28: rtPeptides, rtAntimalarial, rtand
Chapter rt01: rtDrug rtDevelopment rtand Anthelmintic
rtEthical rtConsiderations Chapter rt29: rtHIV- rtand rtAIDS-Related
Chapter rt02: rtPharmacokinetics, rtDrugs
rtPharmacodynamics, rtand Chapter rt30: rtTransplant rtDrugs
rtPharmacogenetics rtChapter rt31: rtVaccines
Chapter rt03: rtCultural rtConsiderations rtChapter rt32: rtAnticancer
rtChapter rt04: rtComplementary rtand rtDrugs
rtAlternative rtTherapies Chapter rt33: rtTargeted rtTherapies rtto rtTreat
Chapter rt05: rtPediatric rtConsiderations rtCancer
rtChapter rt06: rtGeriatric Chapter rt34: rtBiologic rtResponse
rtConsiderations rtChapter rt07: rtDrugs rtModifiers
rtin rtSubstance rtUse rtDisorder Chapter rt35: rtUpper rtRespiratory
Chapter rt08: rtThe rtNursing rtProcess rtand rtDisorders
rtPatient-Centered rtCare Chapter rt36: rtLower rtRespiratory
Chapter rt09: rtSafety rtand rtQuality rtDisorders
rtChapter rt10: rtDrug rtAdministration Chapter rt37: rtCardiac rtGlycosides,
rtChapter rt11: rtDrug rtCalculations rtAntianginals, rtand rtAntidysrhythmics
rtChapter rt12: rtFluid rtVolume rtand rtChapter rt38: rtDiuretics
rtElectrolytes Chapter rt39: rtAntihypertensive
Chapter rt13: rtVitamin rtand rtMineral Chapter rt40: rtAnticoagulants,
rtReplacement rtAntiplatelets, rtand rtThrombolytics
Chapter rt14: rtNutritional rtSupport rtChapter rt41: rtAntihyperlipidemics rtand
rtChapter rt15: rtAdrenergic rtAgonists rtand rtPeripheral rtVasodilators
rtAntagonists Chapter rt42: rtGastrointestinal rtTract
Chapter rt16: rtCholinergic rtAgonists rtand rtDisorders
rtAntagonists Chapter rt43: rtAntiulcer rtDrugs
Chapter rt17: rtStimulants rtChapter rt44: rtEye rtand rtEar
Chapter rt18: rtDepressants rtDisorders rtChapter rt45:
rtChapter rt19: rtAntiseizure rtDrugs rtDermatologic rtDisorders rtChapter
Chapter rt20: rtDrugs rtfor rtParkinsonism rtand rt46: rtPituitary, rtThyroid, rtParathyroid,
rtAlzheimer's rtDisease rtand rtAdrenal rtDisorders rtChapter
Chapter rt21: rtDrugs rtfor rtNeuromuscular rt47: rtAntidiabetics
rtDisorders rtand rtMuscle rtSpasms Chapter rt48: rtUrinary rtDisorders
rtChapter rt22: rtAntipsychotics rtand rtChapter rt49: rtPregnancy rtand rtPreterm
rtAnxiolytics rtLabor
Chapter rt23: rtAntidepressants rtand rtMood Chapter rt50: rtLabor, rtDelivery, rtand
rtStabilizers rtPostpartum
Chapter rt24: rtAntiinflammatories Chapter rt51: rtNeonatal rtand
Chapter rt25: rtAnalgesics rtNewborn rtChapter rt52: rtW omen's
Chapter rt26: rtAntibacterials rtReproductive rtHealth
Chapter rt27: rtAntituberculars, rtAntifungals, Chapter rt53: rtMen's rtReproductive rtHealth
rtand rtAntivirals rtChapter rt54: rtSexually rtTransmitted
rtInfections
Chapter rt55: rtAdult rtand rtPediatric
,Test rtBank rt- rtPharmacology: rtA rtPatient-Centered rtNursing rtProcess rtApproach rt(9th rtEdition,
rt2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Emergency rtDrugs
, Test rtBank rt- rtPharmacology: rtA rtPatient-Centered rtNursing rtProcess rtApproach rt(9th rtEdition,
rt2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
rt rt rt rt rt rt
MULTIPLE rtCHOICE
1. The rtnurse rtis rtpreparing rtto rtadminister rta rtschedule rtII rtinjectable rtdrug rtand rtis rtdrawing rtup rthalf
rtof rtthe rtcontents rtof rta rtSingle-use rtvial. rtWhich rtnursing rtaction rtis rtcorrect?
a. Ask rtanother rtnurse rtto rtobserve rtand rtcosign rtwasting rtthe rtremaining rtdrug rtfrom rtthe rtvial.
b. Keep rtthe rtremaining rtamount rtin rtthe rtpatient’s rtdrawer rtto rtgive rtat rtthe rtnext rtdose.
c. Record rtthe rtamount rtunused rtin rtthe rtpatient’s rtmedication rtrecord.
d. Dispose rtof rtthe rtvial rtwith rtthe rtremaining rtdrug rtinto rta rtlocked rtcollection
rtbox. rtANS: rtA
Schedule rtII rtdrugs rtare rtcontrolled rtsubstances, rtand rtall rtmust rtbe rtaccounted rtfor. rtWhen rtwasting rta
rtportion rtof rta rtdrug, rtanother rtnurse rtshould rtobserve rtand rtcosign rtthat rta rtdrug rtwas rtwasted.
DIF: rtCOGNITIVE rtLEVEL: rtApplying rt(Application)
rtTOP: rtNURSING rtPROCESS: rtNursing rtIntervention
MSC: rtNCLEX: rtPhysiological rtIntegrity: rtPharmacological rtand rtParenteral rtTherapies
2. A rtpatient rtis rtprescribed rta rtmedication rtand rtasks rtthe rtnurse rtif rtthe rtdrug rtis rtavailable rtin rta
rtgeneric rtform. rtThe rtnurse rtunderstands rtthat rta rtgeneric rtmedication rtwill rthave rta rtname rtthat
a. is rta rtregistered rttrademark.
b. is rtalways rtcapitalized.
c. describes rtthe rtdrugs rtchemical rtstructure.
d. is rtnon-proprietary.
rtANS: rtD
The rtgeneric rtname rtis rtthe rtofficial, rtnon-proprietary rtname rtfor rta rtdrug. rtThe rtbrand rtname rtis rtthe
rttrademark rtname rtand rtis rtalways rtcapitalized. rtThe rtchemical rtname rtdescribes rtthe rtchemical
rtstructure rtof rtthe rtdrug.
DIF: rtCOGNITIVE rtLEVEL: rtUnderstanding rt(Comprehension)
rtTOP: rtNURSING rtPROCESS: rtN/A
MSC: rtNCLEX: rtPhysiological rtIntegrity: rtPharmacological rtand rtParenteral rtTherapies
3. A rtpatient rtreceives rta rtprescription rton rtwhich rtthe rtprovider rthas rtnoted rtthat rta rtgeneric
rtmedication rtmay rtbe rtgiven.The rtpatient rtasks rtthe rtnurse rtwhat rtthis rtmeans. rtWhat rtwill rtthe
rtnurse rttell rtthe rtpatient rtabout rtgeneric rtdrugs?
a. They rtcontain rtthe rtsame rtinert rtingredients rtas rtbrand-name rtdrugs.
b. They rthave rtchemical rtstructures rtthat rtare rtidentical rtto rtproprietary rtdrugs.
c. They rttend rtto rtbe rtless rtexpensive rtthan rtbrand-name rtdrugs.
d. They rtundergo rtextensive rttesting rtbefore rtthey rtare
rtmarketed. rtANS: rtC
Generic rtdrugs rtare rtapproved rtby rtthe rtFDA rtif rtthey rtare rtproved rtto rtbe rtbioequivalent rtto rtthe
rtbrand- rtname rtdrug. rtThey rttend rtto rtbe rtless rtexpensive rtbecause rtmanufacturers rtof rtthese rtdrugs
rtdo rtnot rthave rtto rtdo rtthe rtextensive rttesting rtrequired rtof rtbrand-name rtdrugs rtbefore rtmarketing.
rtThey rtare rtnot rtidentical rtto rtbrand-name rtdrugs rtand rtoften rthave rtdifferent rtinert rtingredients.
DIF: rtCOGNITIVE rtLEVEL: rtApplying rt(Application)
TOP: rtNURSING rtPROCESS: rtNursing rtIntervention: rtPatient rtTeaching
rtMSC: rtNCLEX: rtManagement rtof rtClient rtCare
4. The rtnurse rtreviews rtinformation rtabout rta rtdrug rtand rtnotes rtthe rtinitials rtUSP rtafter rtthe rtdrugs
rtofficial rtname. rtThe rtnurse rtunderstands rtthat rtthis rtdesignation rtindicates rtthe rtdrug
a. is rta rtcontrolled rtsubstance.
PHARMACOLOGY rt9TH rtEDITION rtMCCUISTION rtTEST rtBANK
This rtis rta rtset rtof rtquestions rtto rtanswer rtthe rtquestions rtof rtthe rttextbook rt"Pharmacology: rtA rtPatient-
Centered rtNursing rtProcess rtApproach rt9th rtEdition" rtit rthelps rtyou rtto rtbetter rtunderstand rtthe rtbook
rtcorrectly.
Get rtthe rtright rtdosage rtof rtpharmacology rtcontent rtto rtsucceed rton rtthe rtNCLEX rtand rtas rta rtprofessional
rtnurse rtwith rt"Pharmacology: rtA rtPatient-Centered rtNursing rtProcess rtApproach, rt9th rtEdition". rtUsing rta
rtstreamlined rtprototype rtapproach rtand rtan rtemphasis rton rtnursing rtcare, rtthis rttext rtmakes rtit rteasy rtfor
rttoday’s rtnursing rtstudents rtto rtbetter rtunderstand rtthe rtcomplicated rtsubject rtof rtpharmacology. rtThe
rtbook’s rtdetailed rtchapter rton rtdosage rtcalculation, rtthe rtnursing rtprocess rtframework rtfor rtdrug rttherapy,
rtstrong rtQSEN rtfocus, rtand rtsummaries rtof rtprototype rtdrugs rthelp rtdeliver rtthe rtperfect.
,Test rtBank rt- rtPharmacology: rtA rtPatient-Centered rtNursing rtProcess rtApproach rt(9th rtEdition,
rt2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Table of Contents
rt rt
Table rtof rtContents Chapter rt28: rtPeptides, rtAntimalarial, rtand
Chapter rt01: rtDrug rtDevelopment rtand Anthelmintic
rtEthical rtConsiderations Chapter rt29: rtHIV- rtand rtAIDS-Related
Chapter rt02: rtPharmacokinetics, rtDrugs
rtPharmacodynamics, rtand Chapter rt30: rtTransplant rtDrugs
rtPharmacogenetics rtChapter rt31: rtVaccines
Chapter rt03: rtCultural rtConsiderations rtChapter rt32: rtAnticancer
rtChapter rt04: rtComplementary rtand rtDrugs
rtAlternative rtTherapies Chapter rt33: rtTargeted rtTherapies rtto rtTreat
Chapter rt05: rtPediatric rtConsiderations rtCancer
rtChapter rt06: rtGeriatric Chapter rt34: rtBiologic rtResponse
rtConsiderations rtChapter rt07: rtDrugs rtModifiers
rtin rtSubstance rtUse rtDisorder Chapter rt35: rtUpper rtRespiratory
Chapter rt08: rtThe rtNursing rtProcess rtand rtDisorders
rtPatient-Centered rtCare Chapter rt36: rtLower rtRespiratory
Chapter rt09: rtSafety rtand rtQuality rtDisorders
rtChapter rt10: rtDrug rtAdministration Chapter rt37: rtCardiac rtGlycosides,
rtChapter rt11: rtDrug rtCalculations rtAntianginals, rtand rtAntidysrhythmics
rtChapter rt12: rtFluid rtVolume rtand rtChapter rt38: rtDiuretics
rtElectrolytes Chapter rt39: rtAntihypertensive
Chapter rt13: rtVitamin rtand rtMineral Chapter rt40: rtAnticoagulants,
rtReplacement rtAntiplatelets, rtand rtThrombolytics
Chapter rt14: rtNutritional rtSupport rtChapter rt41: rtAntihyperlipidemics rtand
rtChapter rt15: rtAdrenergic rtAgonists rtand rtPeripheral rtVasodilators
rtAntagonists Chapter rt42: rtGastrointestinal rtTract
Chapter rt16: rtCholinergic rtAgonists rtand rtDisorders
rtAntagonists Chapter rt43: rtAntiulcer rtDrugs
Chapter rt17: rtStimulants rtChapter rt44: rtEye rtand rtEar
Chapter rt18: rtDepressants rtDisorders rtChapter rt45:
rtChapter rt19: rtAntiseizure rtDrugs rtDermatologic rtDisorders rtChapter
Chapter rt20: rtDrugs rtfor rtParkinsonism rtand rt46: rtPituitary, rtThyroid, rtParathyroid,
rtAlzheimer's rtDisease rtand rtAdrenal rtDisorders rtChapter
Chapter rt21: rtDrugs rtfor rtNeuromuscular rt47: rtAntidiabetics
rtDisorders rtand rtMuscle rtSpasms Chapter rt48: rtUrinary rtDisorders
rtChapter rt22: rtAntipsychotics rtand rtChapter rt49: rtPregnancy rtand rtPreterm
rtAnxiolytics rtLabor
Chapter rt23: rtAntidepressants rtand rtMood Chapter rt50: rtLabor, rtDelivery, rtand
rtStabilizers rtPostpartum
Chapter rt24: rtAntiinflammatories Chapter rt51: rtNeonatal rtand
Chapter rt25: rtAnalgesics rtNewborn rtChapter rt52: rtW omen's
Chapter rt26: rtAntibacterials rtReproductive rtHealth
Chapter rt27: rtAntituberculars, rtAntifungals, Chapter rt53: rtMen's rtReproductive rtHealth
rtand rtAntivirals rtChapter rt54: rtSexually rtTransmitted
rtInfections
Chapter rt55: rtAdult rtand rtPediatric
,Test rtBank rt- rtPharmacology: rtA rtPatient-Centered rtNursing rtProcess rtApproach rt(9th rtEdition,
rt2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Emergency rtDrugs
, Test rtBank rt- rtPharmacology: rtA rtPatient-Centered rtNursing rtProcess rtApproach rt(9th rtEdition,
rt2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
rt rt rt rt rt rt
MULTIPLE rtCHOICE
1. The rtnurse rtis rtpreparing rtto rtadminister rta rtschedule rtII rtinjectable rtdrug rtand rtis rtdrawing rtup rthalf
rtof rtthe rtcontents rtof rta rtSingle-use rtvial. rtWhich rtnursing rtaction rtis rtcorrect?
a. Ask rtanother rtnurse rtto rtobserve rtand rtcosign rtwasting rtthe rtremaining rtdrug rtfrom rtthe rtvial.
b. Keep rtthe rtremaining rtamount rtin rtthe rtpatient’s rtdrawer rtto rtgive rtat rtthe rtnext rtdose.
c. Record rtthe rtamount rtunused rtin rtthe rtpatient’s rtmedication rtrecord.
d. Dispose rtof rtthe rtvial rtwith rtthe rtremaining rtdrug rtinto rta rtlocked rtcollection
rtbox. rtANS: rtA
Schedule rtII rtdrugs rtare rtcontrolled rtsubstances, rtand rtall rtmust rtbe rtaccounted rtfor. rtWhen rtwasting rta
rtportion rtof rta rtdrug, rtanother rtnurse rtshould rtobserve rtand rtcosign rtthat rta rtdrug rtwas rtwasted.
DIF: rtCOGNITIVE rtLEVEL: rtApplying rt(Application)
rtTOP: rtNURSING rtPROCESS: rtNursing rtIntervention
MSC: rtNCLEX: rtPhysiological rtIntegrity: rtPharmacological rtand rtParenteral rtTherapies
2. A rtpatient rtis rtprescribed rta rtmedication rtand rtasks rtthe rtnurse rtif rtthe rtdrug rtis rtavailable rtin rta
rtgeneric rtform. rtThe rtnurse rtunderstands rtthat rta rtgeneric rtmedication rtwill rthave rta rtname rtthat
a. is rta rtregistered rttrademark.
b. is rtalways rtcapitalized.
c. describes rtthe rtdrugs rtchemical rtstructure.
d. is rtnon-proprietary.
rtANS: rtD
The rtgeneric rtname rtis rtthe rtofficial, rtnon-proprietary rtname rtfor rta rtdrug. rtThe rtbrand rtname rtis rtthe
rttrademark rtname rtand rtis rtalways rtcapitalized. rtThe rtchemical rtname rtdescribes rtthe rtchemical
rtstructure rtof rtthe rtdrug.
DIF: rtCOGNITIVE rtLEVEL: rtUnderstanding rt(Comprehension)
rtTOP: rtNURSING rtPROCESS: rtN/A
MSC: rtNCLEX: rtPhysiological rtIntegrity: rtPharmacological rtand rtParenteral rtTherapies
3. A rtpatient rtreceives rta rtprescription rton rtwhich rtthe rtprovider rthas rtnoted rtthat rta rtgeneric
rtmedication rtmay rtbe rtgiven.The rtpatient rtasks rtthe rtnurse rtwhat rtthis rtmeans. rtWhat rtwill rtthe
rtnurse rttell rtthe rtpatient rtabout rtgeneric rtdrugs?
a. They rtcontain rtthe rtsame rtinert rtingredients rtas rtbrand-name rtdrugs.
b. They rthave rtchemical rtstructures rtthat rtare rtidentical rtto rtproprietary rtdrugs.
c. They rttend rtto rtbe rtless rtexpensive rtthan rtbrand-name rtdrugs.
d. They rtundergo rtextensive rttesting rtbefore rtthey rtare
rtmarketed. rtANS: rtC
Generic rtdrugs rtare rtapproved rtby rtthe rtFDA rtif rtthey rtare rtproved rtto rtbe rtbioequivalent rtto rtthe
rtbrand- rtname rtdrug. rtThey rttend rtto rtbe rtless rtexpensive rtbecause rtmanufacturers rtof rtthese rtdrugs
rtdo rtnot rthave rtto rtdo rtthe rtextensive rttesting rtrequired rtof rtbrand-name rtdrugs rtbefore rtmarketing.
rtThey rtare rtnot rtidentical rtto rtbrand-name rtdrugs rtand rtoften rthave rtdifferent rtinert rtingredients.
DIF: rtCOGNITIVE rtLEVEL: rtApplying rt(Application)
TOP: rtNURSING rtPROCESS: rtNursing rtIntervention: rtPatient rtTeaching
rtMSC: rtNCLEX: rtManagement rtof rtClient rtCare
4. The rtnurse rtreviews rtinformation rtabout rta rtdrug rtand rtnotes rtthe rtinitials rtUSP rtafter rtthe rtdrugs
rtofficial rtname. rtThe rtnurse rtunderstands rtthat rtthis rtdesignation rtindicates rtthe rtdrug
a. is rta rtcontrolled rtsubstance.
